JP2019054792A - 抗酸化能評価方法及びトレーニングメニューの最適化方法 - Google Patents
抗酸化能評価方法及びトレーニングメニューの最適化方法 Download PDFInfo
- Publication number
- JP2019054792A JP2019054792A JP2018176514A JP2018176514A JP2019054792A JP 2019054792 A JP2019054792 A JP 2019054792A JP 2018176514 A JP2018176514 A JP 2018176514A JP 2018176514 A JP2018176514 A JP 2018176514A JP 2019054792 A JP2019054792 A JP 2019054792A
- Authority
- JP
- Japan
- Prior art keywords
- gene
- antioxidant
- training menu
- monocytes
- enzyme gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 40
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 40
- 238000012549 training Methods 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 14
- 238000011156 evaluation Methods 0.000 title claims description 10
- 238000005457 optimization Methods 0.000 title claims description 7
- 108090000790 Enzymes Proteins 0.000 claims abstract description 30
- 230000014509 gene expression Effects 0.000 claims abstract description 27
- 210000001616 monocyte Anatomy 0.000 claims abstract description 20
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims abstract description 13
- 239000008280 blood Substances 0.000 claims abstract description 13
- 210000005087 mononuclear cell Anatomy 0.000 claims abstract description 13
- 108020004635 Complementary DNA Proteins 0.000 claims abstract description 12
- 210000004369 blood Anatomy 0.000 claims abstract description 12
- 238000010804 cDNA synthesis Methods 0.000 claims abstract description 12
- 239000002299 complementary DNA Substances 0.000 claims abstract description 12
- 108020004999 messenger RNA Proteins 0.000 claims abstract description 9
- 210000000601 blood cell Anatomy 0.000 claims abstract description 8
- 238000000926 separation method Methods 0.000 claims abstract description 7
- 238000011529 RT qPCR Methods 0.000 claims abstract description 6
- 238000010839 reverse transcription Methods 0.000 claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 230000036542 oxidative stress Effects 0.000 claims description 8
- 102000016938 Catalase Human genes 0.000 claims description 7
- 108010053835 Catalase Proteins 0.000 claims description 7
- 102100033039 Glutathione peroxidase 1 Human genes 0.000 claims description 7
- 101001014936 Homo sapiens Glutathione peroxidase 1 Proteins 0.000 claims description 7
- 102100030710 NAD-dependent protein deacetylase sirtuin-3, mitochondrial Human genes 0.000 claims description 7
- 108091005770 SIRT3 Proteins 0.000 claims description 7
- 108010021188 Superoxide Dismutase-1 Proteins 0.000 claims description 7
- 102100038836 Superoxide dismutase [Cu-Zn] Human genes 0.000 claims description 7
- 102100032891 Superoxide dismutase [Mn], mitochondrial Human genes 0.000 claims description 7
- 108010045815 superoxide dismutase 2 Proteins 0.000 claims description 7
- 230000004898 mitochondrial function Effects 0.000 claims description 4
- 108010057639 sulfide quinone reductase Proteins 0.000 claims description 3
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 claims description 2
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 claims description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 claims description 2
- 210000005259 peripheral blood Anatomy 0.000 abstract description 5
- 239000011886 peripheral blood Substances 0.000 abstract description 5
- 230000002194 synthesizing effect Effects 0.000 abstract description 3
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 108700026220 vif Genes Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 235000020827 calorie restriction Nutrition 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000001964 muscle biopsy Methods 0.000 description 1
- 150000002978 peroxides Chemical group 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017180644 | 2017-09-20 | ||
| JP2017180644 | 2017-09-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019054792A true JP2019054792A (ja) | 2019-04-11 |
| JP2019054792A5 JP2019054792A5 (https=) | 2020-05-07 |
Family
ID=66106011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018176514A Pending JP2019054792A (ja) | 2017-09-20 | 2018-09-20 | 抗酸化能評価方法及びトレーニングメニューの最適化方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2019054792A (https=) |
-
2018
- 2018-09-20 JP JP2018176514A patent/JP2019054792A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Petré et al. | The effect of two different concurrent training programs on strength and power gains in highly-trained individuals | |
| Verce et al. | A combined metagenomics and metatranscriptomics approach to unravel Costa Rican cocoa box fermentation processes reveals yet unreported microbial species and functionalities | |
| Massidda et al. | New genetic model for predicting phenotype traits in sports | |
| Mägi et al. | The association analysis between ACE and ACTN3 genes polymorphisms and endurance capacity in young cross-country skiers: longitudinal study | |
| Davison | Exercise and oxidative damage in nucleoid DNA quantified using single cell gel electrophoresis: present and future application | |
| Soares et al. | The influence of CYP1A2 genotype in the blood pressure response to caffeine ingestion is affected by physical activity status and caffeine consumption level | |
| Wu et al. | A hyperaccumulator plant Sedum alfredii recruits Cd/Zn-tolerant but not Pb-tolerant endospheric bacterial communities from its rhizospheric soil | |
| Adler et al. | Evolution of the oral microbiome and dental caries | |
| Shah et al. | Trifolium repens and T. subterraneum modify their nodule microbiome in response to soil pH | |
| Gasser et al. | Accelerated muscle deoxygenation in aerobically fit subjects during exhaustive exercise is associated with the ACE insertion allele | |
| Lopes et al. | The effect of active recovery on power performance during the bench press exercise | |
| JP2019054792A (ja) | 抗酸化能評価方法及びトレーニングメニューの最適化方法 | |
| Salman et al. | A comparison of glutathione and malondialdehyde concentrations in athletes engaged in certain sports | |
| Zhang et al. | Empty-nest elderly: mahjong and Chinese square dance for improving the cognitive function in the community | |
| Huang et al. | Circulating cell-free DNA levels correlate with postresuscitation survival rates in out-of-hospital cardiac arrest patients | |
| Tjora et al. | Troponin rise in healthy subjects during exercise test | |
| Mackova et al. | Skeletal muscle characteristics of sprint cyclists and nonathletes | |
| Norberto et al. | Two different approaches to dry-land training do not improve the water performance of swimmers | |
| Cieszczyk et al. | The angiotensin converting enzyme gene I/D polymorphism in ellite Polish and Lithuanian judo players | |
| Rosa et al. | Can a genetic profile be related to performance in young talent track and field athletes? A pilot study | |
| Verlengia et al. | Effect of Walking and Running on the Cardiorespiratory System, Muscle Injury, and the Antioxidant System after 30 Min at the Walk-Run Transition Speed. | |
| Jemili et al. | Biochemical status, oxidative and antioxidant responses after 3-month specific training in elite karate athletes | |
| de Oliveira Zanetti et al. | Long-term heat acclimation training in mice: Similar metabolic and running performance adaptations despite a lower absolute intensity than training at temperate conditions | |
| Voroshin et al. | Dependence of endurance performance on ACE gene polymorphism in athletes | |
| Premužić et al. | Longer Telomere Length in Patients with Balkan Endemic Nephropathy Undergoing Chronic Hemodialysis Is Associated with Lower Cardiovascular Mortality |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20181019 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200327 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200327 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20200327 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20200521 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200609 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20201222 |